Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group

doi:10.3899/jrheum.201679

. 2021 Jun:97:60-63.

doi: 10.3899/jrheum.201679.

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group

Ying Ying Leung¹, Ana-Maria Orbai², William Tillett³, Alexis Ogdie⁴, Lihi Eder⁵, Niti Goel⁶, Pil Hojgaard⁷, Richard Holland⁸, Ashish J Mathew⁹, Christine A Lindsay¹⁰, Anna Antony¹¹, Jeffrey Chau¹², Robin Christensen¹³, Laura C Coates¹⁴, Philip J Mease¹⁵, Vibeke Strand¹⁶, Oliver FitzGerald¹⁷, Maarten de Wit¹⁸, Kristina Callis Duffin¹⁹, Dafna D Gladman²⁰

Affiliations

¹ Y.Y. Leung, MB ChB, MD, Associate Professor, Duke-NUS Medical School, and Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.
² A.M. Orbai, MD, MHS, Assistant Professor of Medicine, Director, Psoriatic Arthritis Program, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
³ W. Tillett, BSc, MB ChB, PhD, MRCP, Consultant Rheumatologist, Senior Lecturer, Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK.
⁴ A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁵ L. Eder, MD, PhD, Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁶ N. Goel, MD, Patient Research Partner, Consultant, Caduceus Biomedical Consulting, LLC, and Adjunct Assistant Professor, Duke University School of Medicine, Durham, North Carolina, USA.
⁷ P. Hojgaard, MD, PhD, Department of Rheumatology, Holbaek Hospital, Holbaek, and the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
⁸ R. Holland, MBBS, Concord Repatriation General Hospital, Sydney, Australia.
⁹ A.J. Mathew, MBBS, DNB, DM, Associate Professor in Rheumatology, Christian Medical College, Vellore, India and Clinical Research Fellow, Psoriatic Arthritis Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
¹⁰ C.A. Lindsay, PharmD, Patient Research Partner, VP Professional and Advocacy Relations, Aurinia Pharma U.S., Inc., Rockville, Maryland, USA.
¹¹ A. Antony, MBBS, Monash University School of Clinical Sciences, Monash Medical Centre, Clayton, Melbourne, Australia.
¹² J. Chau, GRAPPA Patient Research Partner, Hong Kong.
¹³ R. Christensen, BSc, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, and Professor of Biostatistics and Clinical Epidemiology, Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
¹⁴ L.C. Coates, MB ChB, PhD, Associate Professor, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
¹⁵ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health, and University of Washington School of Medicine, Seattle, Washington, USA.
¹⁶ V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.
¹⁷ O. FitzGerald, MD, FRCPI, FRCP(UK), Consultant Rheumatologist and Newman Clinical Research Professor, Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
¹⁸ M. de Wit, PhD, Patient Research Partner, Amsterdam, The Netherlands.
¹⁹ K. Callis Duffin, MD, MS, Department of Dermatology, University of Utah, Salt Lake City, Utah, USA.
²⁰ D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.

PMID: 34074670
DOI: 10.3899/jrheum.201679

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group

Ying Ying Leung et al. J Rheumatol Suppl. 2021 Jun.

. 2021 Jun:97:60-63.

doi: 10.3899/jrheum.201679.

Authors

Affiliations

¹ Y.Y. Leung, MB ChB, MD, Associate Professor, Duke-NUS Medical School, and Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.
² A.M. Orbai, MD, MHS, Assistant Professor of Medicine, Director, Psoriatic Arthritis Program, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
³ W. Tillett, BSc, MB ChB, PhD, MRCP, Consultant Rheumatologist, Senior Lecturer, Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK.
⁴ A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁵ L. Eder, MD, PhD, Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
⁶ N. Goel, MD, Patient Research Partner, Consultant, Caduceus Biomedical Consulting, LLC, and Adjunct Assistant Professor, Duke University School of Medicine, Durham, North Carolina, USA.
⁷ P. Hojgaard, MD, PhD, Department of Rheumatology, Holbaek Hospital, Holbaek, and the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
⁸ R. Holland, MBBS, Concord Repatriation General Hospital, Sydney, Australia.
⁹ A.J. Mathew, MBBS, DNB, DM, Associate Professor in Rheumatology, Christian Medical College, Vellore, India and Clinical Research Fellow, Psoriatic Arthritis Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
¹⁰ C.A. Lindsay, PharmD, Patient Research Partner, VP Professional and Advocacy Relations, Aurinia Pharma U.S., Inc., Rockville, Maryland, USA.
¹¹ A. Antony, MBBS, Monash University School of Clinical Sciences, Monash Medical Centre, Clayton, Melbourne, Australia.
¹² J. Chau, GRAPPA Patient Research Partner, Hong Kong.
¹³ R. Christensen, BSc, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, and Professor of Biostatistics and Clinical Epidemiology, Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
¹⁴ L.C. Coates, MB ChB, PhD, Associate Professor, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
¹⁵ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health, and University of Washington School of Medicine, Seattle, Washington, USA.
¹⁶ V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.
¹⁷ O. FitzGerald, MD, FRCPI, FRCP(UK), Consultant Rheumatologist and Newman Clinical Research Professor, Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
¹⁸ M. de Wit, PhD, Patient Research Partner, Amsterdam, The Netherlands.
¹⁹ K. Callis Duffin, MD, MS, Department of Dermatology, University of Utah, Salt Lake City, Utah, USA.
²⁰ D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.

PMID: 34074670
DOI: 10.3899/jrheum.201679

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group provided updates at the 2020 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. Working groups were set up for the 4 prioritized domains: enthesitis, fatigue, structural damage, and physical function. Two instruments for measurement of physical function were provisionally endorsed: (1) the Health Assessment Questionnaire-Disability Index and (2) the physical functioning domain in the Medical Outcomes Study 36-item Short Form survey.

Keywords: OMERACT; outcome assessment; psoriatic arthritis.

PubMed Disclaimer

Cited by

Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the PARC Cohort.
Allenzara A, Bush K, Husni ME, Reddy SM, Scher JU, Craig E, Koplin J, Walsh JA, Ogdie A. Allenzara A, et al. Arthritis Care Res (Hoboken). 2025 Mar 23;77(8):1007-13. doi: 10.1002/acr.25527. Online ahead of print. Arthritis Care Res (Hoboken). 2025. PMID: 40123255 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group

Affiliations

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Medical

Research Materials

Miscellaneous

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Medical

Research Materials

Miscellaneous